e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – therapy/exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monocytes phagocytosis activity during remission and exacerbation of COPD
J. A. Mikryukova, G. V. Ashyrov, G. L. Ignatova, L. A. Stepanisheva, A. S. Sarsenbaeva (Chelyabinsk, Russian Federation)
Source:
Annual Congress 2006 - COPD – therapy/exacerbations
Session:
COPD – therapy/exacerbations
Session type:
E-Posters in free access
Number:
303
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. A. Mikryukova, G. V. Ashyrov, G. L. Ignatova, L. A. Stepanisheva, A. S. Sarsenbaeva (Chelyabinsk, Russian Federation). Monocytes phagocytosis activity during remission and exacerbation of COPD. Eur Respir J 2006; 28: Suppl. 50, 303
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Neutrophil elastase in severe COPD and asthma exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 36s
Year: 2006
Neutrophil apoptosis and systemic inflammatory markers in acute exacerbation of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 572s
Year: 2003
Tc2 response at the onset of COPD exacerbations
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004
TNFalpha release by monocyte-derived macrophages at stable and exacerbation states in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Acceleration of neutrophilic inflammation during COPD exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
The role of complement activation in COPD exacerbation recovery
Source: ERJ Open Res, 2 (4) 00027-2016; 10.1183/23120541.00027-2016
Year: 2016
Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002
Evaluation of mitochondrial dysfunction of mononuclear leukocytes of smokers and ex-smokers in COPD exacerbation
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 442s
Year: 2005
Reduced spontaneous apoptosis in peripheral blood neutrophils during exacerbation of COPD
Source: Eur Respir J 2004; 23: 532-537
Year: 2004
Cytokines profile of blood and sputum in COPD exacerbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Cytokines profile of blood and sputum in COPD exacerbation
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Does inflammation decrease after recovery from severe exacerbation of COPD?
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Activated neutrophils are increased in bronchial biopsies from patients with severe COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 718s
Year: 2004
Assessment of the phagocytic capability of sputum macrophages and neutrophils in COPD patients.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept